Authority: National Company Law Tribunal (NCLT), Ahmedabad Bench - Court 2
Order Date: July 10, 2026
Case Overview
The petition, registered as CP/44(AHM)2026, was filed by Sparsh Bio-Tech Healthcare Private Limited (the Applicant) against the Secretary of the Ministry of Corporate Affairs and Others (the Respondents). The proceedings are initiated under Section 131 of the Companies Act, 2013. The specific nature of the dispute or the relief sought by the applicant is not detailed in this procedural order. The bench comprised Mrs. Chitra Hankare, Member (Judicial), and Dr. Velamur G Venkata Chalapathy, Member (Technical). The applicant was represented by advocates Mr. Ravi Pahwa and Ms. Gunjan Aggarwal.
Final Outcome
The Tribunal heard the learned counsel for the applicant and issued procedural directions. The applicant is directed to issue notice to all respondents, which include the Registrar of Companies (ROC), the Income Tax Department, and the auditor. The applicant must collect these notices from the registry and serve them to the respondents along with a copy of the petition. Furthermore, the applicant is directed to file an affidavit to comply with 'overseas regularity' (which appears to be a potential transcription error for a standard legal requirement). The matter has been listed for its next hearing and further consideration on September 3, 2026. No substantive decision on the merits of the case was made in this order.
Topics: NCLT Proceeding, Companies Act Compliance, Corporate Petition